Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vaneck Biotech ETF (BBH)

Vaneck Biotech ETF (BBH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 627,451,500
  • Shares Outstanding, K 2,872
  • 60-Month Beta 0.90
Trade BBH with:
  • Price/Earnings ttm 31.66
  • Annual Dividend & Yield 0.61 (0.28%)
  • Most Recent Dividend 0.608 on 12/21/20
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 19.72%
  • Historical Volatility 16.08%
  • IV Percentile 16%
  • IV Rank 17.52%
  • IV High 34.87% on 10/30/20
  • IV Low 16.50% on 06/25/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 2

Price Performance

See More
Period Period Low Period High Performance
1-Month
211.48 +1.48%
on 09/13/21
220.01 -2.45%
on 09/03/21
-0.93 (-0.43%)
since 08/24/21
3-Month
193.88 +10.69%
on 07/15/21
222.22 -3.42%
on 08/10/21
+16.01 (+8.06%)
since 06/24/21
52-Week
150.52 +42.58%
on 10/30/20
222.22 -3.42%
on 08/10/21
+59.57 (+38.42%)
since 09/24/20

Most Recent Stories

More News
Moderna ETFs to Rally on Two-in-One Vaccine Booster Shot News

Moderna is expected to gain on approval for booster shots and new positive data on its COVID-19 vaccine.

MRNA : 430.14 (-5.38%)
IBB : 170.49 (-1.97%)
BBH : 214.61 (-1.83%)
IDNA : 53.50 (-3.10%)
GERM : 43.34 (-2.32%)
Best ETF Areas for Placing Your Bets in September

Let's take a look at some ETF areas that can be good investment options for September.

IBB : 170.49 (-1.97%)
XLK : 156.71 (+0.07%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
IYW : 106.82 (+0.20%)
VGT : 422.56 (+0.01%)
IVE : 148.53 (-0.43%)
MGV : 100.41 (+0.07%)
WFH : 77.72 (+0.34%)
EDUT : 11.29 (-0.96%)
EDOC : 18.31 (-1.82%)
5 Top-Ranked ETFs That Outperformed in August

Let's take a look at some top-ranked ETFs that outperformed Wall Street in August.

PFE : 43.94 (-0.57%)
BBH : 214.61 (-1.83%)
XSD : 208.34 (-0.33%)
IYW : 106.82 (+0.20%)
RPG : 203.35 (+0.01%)
FTXO : 32.28 (+1.00%)
Pfizer Vaccine Approval Triggers a Surge in Biotech ETFs

The biotech space has once again come under the spotlight as the FDA has granted the first full U.S. approval to Pfizer (PFE)/BioNTech's (BNTX) coronavirus vaccine.

PFE : 43.94 (-0.57%)
IBB : 170.49 (-1.97%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)
BNTX : 333.48 (-5.53%)
Biotech ETFs to Benefit From Latest Booster Update

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

PFE : 43.94 (-0.57%)
MRNA : 430.14 (-5.38%)
IBB : 170.49 (-1.97%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)
BNTX : 333.48 (-5.53%)
Moderna ETFs to Shine Bright on Booster Update, New Study Data

Moderna is expected to gain on approval for booster shots and new positive data on its COVID-19 vaccine.

PFE : 43.94 (-0.57%)
MRNA : 430.14 (-5.38%)
IBB : 170.49 (-1.97%)
BBH : 214.61 (-1.83%)
IDNA : 53.50 (-3.10%)
GERM : 43.34 (-2.32%)
How Are Biotech ETFs Reacting to These Q2 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

BIIB : 291.71 (-0.51%)
AMGN : 213.61 (-0.67%)
GILD : 71.19 (-0.70%)
IBB : 170.49 (-1.97%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
ETF Investing Areas to Consider for August

Let's take a look at some ETF areas that can be good investment options for August.

IBB : 170.49 (-1.97%)
XLK : 156.71 (+0.07%)
SDY : 119.05 (+0.02%)
VIG : 158.26 (+0.13%)
NOBL : 90.90 (unch)
XBI : 130.37 (-2.03%)
DVY : 115.97 (-0.65%)
BBH : 214.61 (-1.83%)
IYW : 106.82 (+0.20%)
VGT : 422.56 (+0.01%)
QTEC : 166.95 (+0.11%)
WFH : 77.72 (+0.34%)
EDUT : 11.29 (-0.96%)
EDOC : 18.31 (-1.82%)
Sanofi to Buy mRNA Developer: ETFs in Focus

Sanofi has agreed to acquire U.S. biotech company Translate Bio to gain exposure in the mRNA vaccine space.

PPH : 73.58 (-0.30%)
BBH : 214.61 (-1.83%)
VIRS : 33.76 (-0.71%)
IBBQ : 26.59 (-2.06%)
Delta Variant Surge Brings Biotech ETFs in Focus

The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.

SNY : 47.94 (-1.60%)
AAPL : 146.92 (+0.06%)
TGT : 241.44 (-0.51%)
WMT : 143.17 (+0.28%)
MRNA : 430.14 (-5.38%)
IBB : 170.49 (-1.97%)
TBIO : 37.36 (-0.13%)
FB : 352.96 (+2.02%)
GOOGL : 2,844.30 (+0.71%)
XBI : 130.37 (-2.03%)
BBH : 214.61 (-1.83%)
FBT : 172.90 (-1.17%)
BTEC : 56.41 (-2.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 220.02
2nd Resistance Point 218.82
1st Resistance Point 216.71
Last Price 214.61
1st Support Level 213.40
2nd Support Level 212.20
3rd Support Level 210.09

See More

52-Week High 222.22
Last Price 214.61
Fibonacci 61.8% 194.83
Fibonacci 50% 186.37
Fibonacci 38.2% 177.91
52-Week Low 150.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar